QualityStocksNewsBreaks Archives - Page 839 of 1423

WednesdayNov 04, 2020 1:00 pm

QualityStocksNewsBreaks – Siyata Mobile Inc. (NASDAQ: SYTA) (TSX.V: SIM) Notes Execution of Over-Allotment Option

Siyata Mobile (NASDAQ: SYTA, SYTAW) (TSX.V: SIM), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, announced that underwriters have partially exercised the over-allotment option outlined in SYTA’s U.S. initial public offering; that offering closed on Sept. 29, 2020. Consequently, Siyata has issued an additional 120,000 common shares in the capital of the company along with 266,000 additional common share purchase warrants, resulting in aggregate gross proceeds of $721,460. Siyata has announced that net proceeds from the offering will be earmarked for sales and marketing, growth capital, and research and development with any remaining…

WednesdayNov 04, 2020 12:37 pm

QualityStocksNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) to Report Q3 2020 Financial Results, Host Conference Call

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced that it will release financial results for its second quarter ended September 30, 2020, on Thursday, Nov. 12, 2020, as well as host a conference call at 9:00 a.m. Eastern Time. According to the update, Erez Raphael, chief executive officer, Rick Anderson, president and general manager of North America and Zvi Ben-David, chief financial officer will host the call. Interested parties may register via the webcast link and join the call by dialing 844-369-8770 (Toll-Free) or 862-298-0840 (International) and providing the following conference ID: DarioHealth Third Quarter…

WednesdayNov 04, 2020 12:14 pm

QualityStocksNewsBreaks – Cannabis Global Inc. (CBGL) Announces Filing of Patent for New Class of ‘Revolutionary’ Nano Cannabinoid

Cannabis Global (OTC: CBGL), a cannabinoid and hemp extract science-forward company developing unique infusion technologies and products, has filed a new patent application. The nonprovisional application is a direct result of CBGL’s Project Varin and expands on the technologies and developments contained in the company’s provisional applications filed on Nov. 4, 2019. This recent application outlines new methods for the manufacture of highly bioavailable and ultra-fast-acting cannabinoids for use in a variety of applications, including in beverages, food and topicals. Calling the technology “revolutionary,” the announcement notes that this patent may rewrite the efficacy and cost equations in the cannabis…

WednesdayNov 04, 2020 11:42 am

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Integrates QuadSight(R) Software on the NVIDIA(R) Jetson AGX Xavier(TM) Platform

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced completion of its QuadSight(R) software on the NVIDIA(R) Jetson AGX Xavier(TM) platform, suitable for shuttles, agriculture, heavy equipment machines and more. “Foresight’s revolutionary stereoscopic vision solutions are based on advanced algorithms for image processing, 3D video analysis and sensor fusion. Our solutions require cutting-edge computing infrastructure that enables high performance advanced image processing algorithms,” David Lempert, Foresight’s vice president of R&D, said in the press release. “We are confident that NVIDIA’s platforms offer the best possible solutions for our needs. As more and more players…

WednesdayNov 04, 2020 11:16 am

QualityStocksNewsBreaks – Jupiter Wellness Inc. (NASDAQ: JUPW) Closes Initial Public Offering

Jupiter Wellness (NASDAQ: JUPW), a cutting-edge wellness brand dedicated to exploring the multiple therapeutic and medical uses of cannabidiol (“CBD”) via a multitude of convenient products, announced the closing of its initial public offering. The IPS comprised 933,333 units consisting of one share of common stock and one warrant, with gross proceeds of $7 million before offering expenses are deducted. The units were traded under the symbols of “JUPW” and “JUPWW” on the Nasdaq Capital Market beginning Oct. 30, 2020. Aegis Capital Corporation, which acted as the sole book running manager for the offering, also exercised an option to purchase…

WednesdayNov 04, 2020 10:36 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) Puts DRIVRZ in Front of Millions of US Consumers Through Strategic Partnership

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA), a fintech provider disrupting the automotive industry, today announced its entry into a letter of intent with CB Auto Group Inc. Under the agreement, PowerBand will provide CB Auto's membership (which currently amasses 17 million) with direct access to PowerBand's virtual platform — DRIVRZ. “This partnership will put DRIVRZ in front of millions of U.S. consumers who will be able to buy, lease, sell, trade and finance a car and truck from their smart phone, as easily as buying a product on Amazon,” said PowerBand CEO Kelly Jennings. “This is another important…

WednesdayNov 04, 2020 10:08 am

QualityStocksNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Reschedules Webcast for Nov. 4, 2020

Energy Fuels (NYSE American: UUUU) (TSX: EFR) on Tuesday announced that, due to technical issues, its conference call and webcast originally scheduled for Nov. 3, 2020, has been postponed to be held at 4:00 pm ET on Nov. 4, 2020. Interested parties may join the webcast and access presentations and viewer-controlled slides via the following link: https://ibn.fm/7EfVh. In addition, participants may dial 1-888-664-6392 (toll free in the U.S. and Canada) to join the webcast and ask questions. A recorded version will be available shortly after conclusion of the webcast by dialing 1-888-390-0541 (toll free in the U.S. and Canada) and entering…

WednesdayNov 04, 2020 9:36 am

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Featured in Research Report

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, was featured in an institutional research report by Craig-Hallum Capital Group LLC. The report discusses Craig-Hallum’s research coverage of PCSA and details the company’s experienced management team and its ownership rights to five programs that are de-risked by existing data. The piece reads, “By early next year, PCSA expects to begin three clinical trials – PCS499 in Phase IIb to treat necrobiosis lipoidica (‘NL’), PCS6422 in Phase 1b as an adjunct to the chemotherapy 5-FU,…

TuesdayNov 03, 2020 2:58 pm

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) Featured in Stock2Me Podcast

VistaGen (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. The episode features Shawn K. Singh, CEO of VistaGen, as he discusses the company’s innovative development pipeline and focus on bringing new, effective treatment options for anxiety, depression and other conditions involving the central nervous system (“CNS”) for which the company believes current treatment alternatives are inadequate, resulting in high unmet need. “Throughout the many years I’ve…

TuesdayNov 03, 2020 1:02 pm

QualityStocksNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Host Call, Live Webcast to Discuss Q3 2020 Results, Clinical Pipeline

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients with high unmet medical need conditions, today announced that it will host a conference call and live webcast at 5:30 p.m. Eastern Time on Nov. 12, 2020. Topics will include review of the company’s third quarter 2020 results and an update on its clinical pipeline, including discussion of PCSA’s three clinical-stage drugs (each of which addresses potential billion-dollar markets). Interested parties may join the call by dialing 877-876-9176 (Toll Free) or 785-424-1670 (International) and access the live webcast via the following…

Site Search

Company Search

Category: QualityStocksNewsBreaks